Brandywine Realty Trust has secured two partners — one an undisclosed global institutional investor — on the development of a $287 million project at Schuylkill Yards and is making progress on its lease negotiations with Dechert at Cira Centre. The Philadelphia real estate investment trust said Dechert, one of Philadelphia’s largest law firms, is in… Read more »
Posts By: WCRE
2000 Market Wraps Up $12M in Renovations
Nahla Capital has completed $12 million in interior and exterior renovations to 2000 Market St. and signed a handful of lease renewals at the Center City office building. “We have had good momentum even during the pandemic,” said P.J. Van Hoof, senior associate at Nahla Capital. “We had more smaller tenants that were expiring and with… Read more »
BakerHostetler Signs Deal to Move Philadelphia Office
BakerHostetler has signed a 16-year lease to relocate its Philadelphia offices from Cira Centre in University City to BNY Mellon Center at 1735 Market St. in the Central Business District. The Cleveland-based law firm leased 45,121 square feet, a reduction from the 80,000 square feet it had occupied at Cira Centre. BakerHostetler’s lease was scheduled… Read more »
Wanamaker Reckoning: Tenants Set to Vacate More Than Half of Office Space at Center City Landmark
The Wanamaker building is facing 500,000 square feet of vacant space after Children’s Hospital of Philadelphia exercised an option to terminate its lease at the building and two other tenants decided to move out. The 1.4-million-square-foot building at 100 Penn Square East in Center City has 950,000 square feet of office space and the remainder… Read more »
$8M Redevelopment Planned in South Kensington as Buyer Seeks ‘Critical Mass’ in Neighborhood
A Charlotte real estate firm has paid $9.45 million for a 78,000-square-foot building at 1400 N. Howard St. in Philadelphia and plans to invest another $8 million to redevelop it. While the Charlotte real estate firm owns several High Street retail properties near Rittenhouse Square including 1704 Walnut St., it also has a growing presence… Read more »
Axalta to Close Center City Headquarters Office
Axlata Coating Systems Ltd. plans to close its Center City global headquarters office and move out of the 36,000 square feet it has occupied at Two Commerce Square for the last seven years. Employees working out of Philadelphia will relocate to either its 55,000-square-foot North American headquarters off Applied Bank Way in Glen Mills or… Read more »
Suburbs are in Vogue’: Swedesford Road Office Buildings Hit the Market
The properties being marketed are: 656-676 E. Swedesford Road, a two-building complex that totals 147,000 square feet; and the Valley Forge Office Center, which includes 480 E. Swedesford Road, a 49,000-square-foot building, and 500 E. Swedesford Road, a 61,000-square-foot property. No prices have been set for the buildings. The complex at 656-676 E. Swedesford was… Read more »
Most Brandywine Office Tenants Still at Home as Public Health Issues Stymie Companies
As many as 85% of tenants in one office landlord’s buildings across the country are still working from home, and its executives say large employers are realizing they may have more of a struggle on their hands in getting everyone back than first anticipated. Brandywine Realty Trust executives are finding that even as some tenant… Read more »
Fully Approved Philly Medical Space for Sale or Lease
Wolf Commercial Real Estate, the leading Philly commercial real estate broker with experience in Philly commercial real estate listings and services, now has available fully approved, build-to-suit Philly medical space for sale or lease at 2201 East Allegheny Avenue Philadelphia PA. The main building of this Philly medical space for sale or lease contains +/-… Read more »
Imvax Picked the Iconic Curtis Building for its New HQ in Philadelphia
Imvax expected to host an event in April or May to unveil its new headquarters at The Curtis in the Old City section of Philadelphia, but the ongoing pandemic scuttled those plans. “Covid-19 clearly got in the way,” said John Furey, the former Spark Therapeutics executive who was hired as CEO of Imvax last year. “Once… Read more »